Description de l'offre
Scientist - Small Molecule Process Chemistry
Genentech is seeking a top-tier Chemistry Scientist with a proven record of sustained laboratory achievement and innovation to join our Small Molecule Process Chemistry group. The Scientist, leading from the bench as part of our project-based research and development staff, is responsible for: - Developing enabling chemistry during early and/or late stage research in support of early development-readiness decisions - Developing processes to manufacture Active Pharmaceutical Ingredient (API) in early development - Delivering API supply in early phase clinical development Using the enabling chemistry developed, the Scientist, working with our South San Francisco clinical manufacturing team, will participate in the production of early phase GMP clinical supplies. Eventual route selection for late stage GMP API manufacturing is also the responsibility of the Scientist and includes the concepts of safe, efficient, robust, environmentally sound chemistry and extends to the synthesis of the regulatory starting materials and establishment of a robust supply chain. A key job requirement is the ability to interact closely with discovery chemists and sourcing partners throughout development. The Scientist is expected to maintain a high level scientific profile both internally and externally in terms of scholarly achievements and pipeline contributions. The successful candidate will be responsible for developing processes suitable for controlling the quality of bulk API as required by cGMP, ICH and FDA regulations as well as the bulk attributes conducive to successful formulation development. In addition, writing relevant CMC sections of INDs and participating in developing a strategy for quality are important tasks. The position's mission will be accomplished through innovation and teamwork, collaboration with strategic partners, creative problem solving and use of state-of-the-art technology.
At Roche, 94,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we've become one of the world's leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity
Roche is an equal opportunity employer.
Research & Development, Research & Development > ResearchSouth San Francisco
· Who we are
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
Roche is an equal opportunity employer and strictly prohibits unlawful discrimination based upon an individual's race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status, veteran status, or any other characteristic protected by law.
À propos de Roche
La société présente depuis 2004 deux sections parallèles, le secteur pharmaceutique et le secteur diagnostic. Numéro un mondial dans les médicaments contre le cancer ainsi qu'en virologie, le groupe dirigé par le Dr Severin Schwan se focalise essentiellement dans la « médecine individualisée ».
La société est présente commercialement dans 150 pays. Son siège se situe à Bâle en Suisse. Son chiffre d'affaires s'est élevé en 2016 à 50,576 milliards de francs suisses. La société a dépensé 9,915 milliards de francs suisses en recherche et développement. En 2016, l'entreprise compte 94 000 salariés environ